Trial Profile
A retrospective trial of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Rufinamide (Primary)
- Indications Epilepsy; Lennox-Gastaut syndrome
- Focus Therapeutic Use
- 29 Jan 2016 New trial record